In 2019, a study proved that hepatic veno-occlusive disease (VOD) can be reduced by EP by stopping hepatic oxidation through nuclear factor erythroid 2-related factor 2 (Nrf2). This evidence concerns the gene NFE2L2 and hepatic veno-occlusive disease.